• 1.

    Cowan AJ, et al. Diagnosis and management of multiple myeloma: A review. JAMA 2022; 327:464477. doi: 10.1001/jama.2022.0003

  • 2.

    Ho PJ, et al. Renal impairment at diagnosis in myeloma: Patient characteristics, treatment, and impact on outcomes. Results from the Australia and New Zealand myeloma and related diseases registry. Clin Lymphoma Myeloma Leuk 2019; 19:e415e424. doi: 10.1016/j.clml.2019.05.010

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 3.

    Bridoux F, et al. Management of acute kidney injury in symptomatic multiple myeloma. Kidney Int 2021; 99:570580. doi: 10.1016/j.kint.2020.11.010

  • 4.

    Dimopoulos MA, et al. Management of multiple myeloma-related renal impairment: Recommendations from the International Myeloma Working Group. Lancet Oncol 2023; 24:e293e311. doi: 10.1016/S1470-2045(23)00223-1

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 5.

    Chitty DW, et al. Kidney transplantation in patients with multiple myeloma: Narrative analysis and review of the last two decades. Nephrol Dial Transplant 2022; 37:16161626. doi: 10.1093/ndt/gfaa361

    • PubMed
    • Search Google Scholar
    • Export Citation

Myeloma-Related Renal Impairment Management Update

Motoko Yanagita Motoko Yanagita, MD, PhD, is chair and professor of the Department of Nephrology and principal investigator of the Institute for the Advanced Study of Human Biology at Kyoto University, Japan.

Search for other papers by Motoko Yanagita in
Current site
Google Scholar
PubMed
Close
Restricted access
Save